Sarcomas Completed Phase 1 / 2 Trials for Filgrastim (DB00099)

Also known as: Sarcoma / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Soft tissue sarcoma

IndicationStatusPhase
DBCOND0041813 (Sarcomas)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003425Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectTreatment
NCT00005952Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsTreatment
NCT00023738Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue SarcomaTreatment
NCT00118326Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseTreatment
NCT01027910PCI-24781 in Combination With Doxorubicin to Treat SarcomaTreatment